Pennsylvania Allergy & Asthma Society

  • Home
  • About PAAA
    • Mission and Bylaws
    • Officers and Committees
    • Board of Regents Minutes
    • Legislation and Advocacy
    • Membership
    • Corporate Partners >
      • Support Opportunities
  • Events
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • PAERF Posters
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
  • Home
  • About PAAA
    • Mission and Bylaws
    • Officers and Committees
    • Board of Regents Minutes
    • Legislation and Advocacy
    • Membership
    • Corporate Partners >
      • Support Opportunities
  • Events
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • PAERF Posters
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
Picture
Blueprint Medicines
45 Sidney Street
Cambridge, MA 02139
www.blueprintmedicines.com
Social Media
Twitter - @BlueprintMeds
LinkedIn - www.linkedin.com/company/blueprint-medicines

About Blueprint Medicines 
Blueprint Medicines is a company committed to the development and commercialization of precision therapies for people with genomically-defined cancers and hematological disorders. A focus of our clinical development efforts is on addressing the unmet need in indolent systemic mastocytosis. The PIONEER clinical trial (NCT03731260) is a phase 2, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of avapritinib + best supportive care (BSC) with placebo + BSC in patients with indolent systemic mastocytosis whose symptoms are not adequately controlled by BSC. This study is currently open and enrolling eligible patients at multiple centers across the United States and globally.

Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.
© 2021 Blueprint Medicines Corporation.  
05/2021 US-BP-MED-AVAASM-21019



Representatives
Ali Nagle, PhD
Medical Science Liaison – Associate Director
PA, Upstate NY, NJ, DE
anagle@blueprintmedicines.com

Blueprint Medicines Medical Information
medinfo@blueprintmedicines.com
1-888-BLU-PRNT (1-888-258-7768)
Resources
Blueprint PIONEER Trial Card
RETURN TO EXHIBIT GALLERY
Pennsylvania Allergy and Asthma Association.  All Rights Reserved.
 400 Winding Creek Blvd, Mechanicsburg, PA 17050
Phone: (833) 770-1543 |
paaa@paallergy.org
© 2017, Pennsylvania Allergy & Asthma Association. All rights are reserved.

Contact Us | Privacy Policy | Terms of Use | Sitemap
Picture